Glucotrack (GCTK) Net Income towards Common Stockholders (2010 - 2025)
Glucotrack (GCTK) reported Net Income towards Common Stockholders of -$3.5 million for Q4 2025, up 9.52% year-on-year from -$3.2 million in Q4 2024, and up 19.08% quarter-over-quarter from -$4.3 million in Q3 2025.
Glucotrack (GCTK) has 15 years of Net Income towards Common Stockholders data on file, last reported at -$3.5 million in Q4 2025.
- For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 9.52% year-over-year to -$3.5 million; the trailing twelve-month figure through Dec 2025 stood at -$16.1 million (down 10.57% YoY), and the FY2025 full-year result was -$16.1 million, down 10.61% from the prior year.
- Net Income towards Common Stockholders for Q4 2025 stood at -$3.5 million, up from -$4.3 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $2.4 million in Q4 2023 and bottomed at -$4.8 million in Q2 2025.
- A 5-year average of -$1.4 million and a median of -$1.2 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders jumped 229.1% in 2022 and plunged 321.12% in 2024, its largest moves.
- Tracing GCTK's Net Income towards Common Stockholders over 5 years: stood at -$1.5 million in 2021, then jumped by 185.57% to $1.3 million in 2022, then soared by 87.41% to $2.4 million in 2023, then plunged by 259.78% to -$3.9 million in 2024, then gained by 9.52% to -$3.5 million in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$3.5 million, -$4.3 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 398.73 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 135.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 13.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 130.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 112.77 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 72.77 Mn |
| 10 | Glucotrack | 290,858.33 | -7.09 Mn | - | -3.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.49 Mn |
| Sep 30, 2025 | -4.31 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Mar 31, 2025 | -3.50 Mn |
| Dec 31, 2024 | -3.85 Mn |
| Sep 30, 2024 | -3.26 Mn |
| Jun 30, 2024 | -4.49 Mn |
| Mar 31, 2024 | -2.95 Mn |
| Dec 31, 2023 | 2.41 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 928,000.00 |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | -1.50 Mn |
| Sep 30, 2021 | -767,000.00 |
| Jun 30, 2021 | -873,000.00 |
| Mar 31, 2021 | -896,000.00 |
| Dec 31, 2020 | -878,000.00 |
| Sep 30, 2020 | -887,000.00 |
| Jun 30, 2020 | -611,000.00 |
| Mar 31, 2020 | -714,478.00 |
| Dec 31, 2019 | 6.41 Mn |
| Sep 30, 2019 | -980,473.00 |
| Jun 30, 2019 | -894,306.00 |
| Mar 31, 2019 | -1.05 Mn |
| Dec 31, 2018 | -1.01 Mn |
| Sep 30, 2018 | -1.61 Mn |
| Jun 30, 2018 | -2.01 Mn |
| Mar 31, 2018 | 1.91 Mn |
| Dec 31, 2017 | 18.47 Mn |
| Sep 30, 2017 | -2.65 Mn |
| Jun 30, 2017 | -2.66 Mn |
| Mar 31, 2017 | 2.59 Mn |
| Dec 31, 2016 | -1.32 Mn |
| Sep 30, 2016 | -1.71 Mn |
| Jun 30, 2016 | -1.59 Mn |
| Mar 31, 2016 | -1.27 Mn |
| Dec 31, 2015 | -1.56 Mn |
| Sep 30, 2015 | -1.19 Mn |
| Jun 30, 2015 | -1.10 Mn |
| Mar 31, 2015 | -883,287.00 |
| Dec 31, 2014 | -1.01 Mn |
| Sep 30, 2014 | -830,691.00 |
| Jun 30, 2014 | -884,262.00 |
| Mar 31, 2014 | -889,473.00 |
| Dec 31, 2012 | -685,496.00 |
| Sep 30, 2012 | -686,026.00 |
| Jun 30, 2012 | -754,075.00 |
| Mar 31, 2012 | -648,001.00 |
| Dec 31, 2011 | -597,350.00 |
| Sep 30, 2011 | -700,246.00 |
| Jun 30, 2011 | -496,729.00 |
| Mar 31, 2011 | -539,121.00 |
| Dec 31, 2010 | -380,585.00 |